The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma
2020-01-01 Colombo, N; Oza, Am; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Weberpals, Ji; Clamp, Ar; Scambia, G; Leary, A; Holloway, Rw; Gancedo Margarita, A; Fong, Pc; Goh, Jc; O'Malley, Dm; Armstrong, Dk; Banerjee, S; García-Donas, J; Swisher, Em; Meunier, J; Cameron, T; Maloney, L; Goble, S; Bedel, J; Ledermann, Ja; Coleman, Rl
Potential impact of introducing a nonavalent HPV vaccination
2018-01-01 Bogani, G; Taverna, F; Lombardo, C; Signorelli, M; Chiappa, V; Casarin, J; Scaffa, C; Leone Roberti Maggiore, U; Recalcati, D; Ditto, A; Martinelli, F; Borghi, C; Perotto, S; Ferrero, S; Lorusso, D; Raspagliesi, F
Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study
2015-01-01 Konecny, Ge; Finkler, N; Garcia, Aa; Lorusso, D; Lee, Ps; Rocconi, Rp; Fong, Pc; Squires, M; Mishra, K; Upalawanna, A; Wang, Yy; Kristeleit, R
The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer
2017-01-01 Lorusso, D; Fontanella, C; Maltese, G; Lepori, S; Tripodi, E; Bogani, G; Raspagliesi, F.
Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC
2016-01-01 Perrone, F; Baldassarre, G; Indraccolo, S; Signoriello, S; Chiappetta, G; Esposito, F; Ferrandina, G; Franco, R; Mezzanzanica, D; Sonego, M; Zulato, E; Zannoni, Gf; Canzonieri, V; Scambia, G; Sorio, R; Savarese, A; Breda, E; Scollo, P; Ferro, A; Tamberi, S; Febbraro, A; Natale, D; Di Maio, M; Califano, D; Scognamiglio, G; Lorusso, D; Canevari, S; Losito, S; Gallo, C; Pignata, S
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy
2011-01-01 Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.; Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.
Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures
2015-01-01 Ditto, A; Martinelli, F; Bogani, G; Lorusso, D; Carcangiu, M; Chiappa, V; Reato, C; Donfrancesco, C; De Carrillo, Kja; Raspagliesi, F
Advanced vulvar carcinoma: Is it worth operating? A perioperative management protocol for radical and reconstructive surgery
2006-01-01 Fanfani, Francesco; Garganese, Giorgia; Fagotti, Anna; Lorusso, D; Gagliardi Maria, Lucia; Rossi, Marco; Salgarello, Marzia; Scambia, Giovanni
Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer
2022-01-01 Lorusso, D; Guy, H; Samyshkin, Y; Hawkes, C; Estenson, K; Coleman, Rl; Lorusso, D; Guy, H; Samyshkin, Y; Hawkes, C; Estenson, K; Coleman, Rl
Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives
2021-01-01 Maiorano, Ba; Maiorano, Mfp; Lorusso, D; Maiello, E
Treatment of Recurrent Endometrial Carcinoma: Progress Toward a More Personalized Approach
2015-01-01 Bogani, G; Chiappa, V; Lorusso, D; Raspagliesi, F
Phase II Study of NGR-hTNF Plus Doxorubicin in Relapsed Ovarian Cancer (OC)
2011-01-01 Lorusso, D; Scambia, G.; Amadio, G.; Trivellizzi, N.; Pietragalla, A.; De Vincenzo, R.; Salutari, V.; Di Stefano, M.; Lambiase, A.; Bordignon, C.
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
2016-01-01 Mirza, Mr; Monk, Bj; Herrstedt, J; Oza, Am; Mahner, S; Redondo, A; Fabbro, M; Ledermann, Ja; Lorusso, D; Et, Al.
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study
2020-01-01 Brewer, M; Angioli, R; Scambia, G; Lorusso, D; Terranova, C; Benedetti Panici, P; Raspagliesi, F; Scollo, P; Plotti, F; Ferrandina, G; Salutari, V; Ricci, C; Braly, P; Holloway, R; Method, M; Madiyalakan, M; Bayever, E; Nicodemus, C; Brewer, M; Angioli, R; Scambia, G; Lorusso, D; Terranova, C; Benedetti Panici, P; Raspagliesi, F; Scollo, P; Plotti, F; Ferrandina, G; Salutari, V; Ricci, C; Braly, P; Holloway, R; Method, M; Madiyalakan, M; Bayever, E; Nicodemus, C
Incorporating 3D laparoscopy for the management of locally advanced cervical cancer: a comparison with open surgery
2016-01-01 Raspagliesi, F; Bogani, G; Martinelli, F; Signorelli, M; Chiappa, V; Scaffa, C; Sabatucci, I; Adorni, M; Lorusso, D; Ditto, A
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Squamous Cell Carcinoma of the Ovary
2014-01-01 Glasspool, Rm; Martin, Ag; Millan, D; Lorusso, D; Avall-Lundqvist, E; Hurteau, Ja; Davis, A; Hilpert, F; Kim, Jw; Alexandre, J; Ledermann, Ja
Quality of life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer
2018-01-01 Piccirillo, Mc; Scambia, G; Bologna, A; Signoriello, S; Vergote, I; Baumann, K; Lorusso, D; Murgia, V; Sorio, R; Ferrandina, G; Sacco, C; Cormio, G; Breda, E; Cinieri S, ; Natale, D; Mangili, G; Pisano, C; Cecere, Sc; Di Napoli, M; Salutari, V; Raspagliesi F, ; Arenare, L; Bergamini, A; Bryce, J; Daniele, G; Gallo, C; Pignata, S; Perrone, F.
Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer
2003-01-01 D'Agostino, G; Ferrandina, G; Ludovisi, M; Testa, A; Lorusso, D; Gbaguidi, N; Breda, E; Mancuso, S; Scambia, G
Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study
2011-01-01 Marchetti, Claudia; Pisano, Carmela; Mangili, Giorgia; Lorusso, D; Panici Pierluigi, Benedetti; Silvestro, Giustino; Candiani, Massimo; Greggi, Stefano; Perniola, Giorgia; Di Maio, Massimo; Pignata, Sandro
[Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.]
2021-01-01 Danesi, R.; Cremolini, C.; Ciccarone, F.; Lorusso, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| The effect of age on efficacy, safety and patient-centered outcomes with rucaparib: A post hoc exploratory analysis of ARIEL3, a phase 3, randomized, maintenance study in patients with recurrent ovarian carcinoma | 1-gen-2020 | Colombo, N; Oza, Am; Lorusso, D; Aghajanian, C; Oaknin, A; Dean, A; Weberpals, Ji; Clamp, Ar; Scambia, G; Leary, A; Holloway, Rw; Gancedo Margarita, A; Fong, Pc; Goh, Jc; O'Malley, Dm; Armstrong, Dk; Banerjee, S; García-Donas, J; Swisher, Em; Meunier, J; Cameron, T; Maloney, L; Goble, S; Bedel, J; Ledermann, Ja; Coleman, Rl | |
| Potential impact of introducing a nonavalent HPV vaccination | 1-gen-2018 | Bogani, G; Taverna, F; Lombardo, C; Signorelli, M; Chiappa, V; Casarin, J; Scaffa, C; Leone Roberti Maggiore, U; Recalcati, D; Ditto, A; Martinelli, F; Borghi, C; Perotto, S; Ferrero, S; Lorusso, D; Raspagliesi, F | |
| Second-line dovitinib (TKI258) in patients with FGFR2-mutated or FGFR2-non-mutated advanced or metastatic endometrial cancer: a non-randomised, open-label, two-group, two-stage, phase 2 study | 1-gen-2015 | Konecny, Ge; Finkler, N; Garcia, Aa; Lorusso, D; Lee, Ps; Rocconi, Rp; Fong, Pc; Squires, M; Mishra, K; Upalawanna, A; Wang, Yy; Kristeleit, R | |
| The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer | 1-gen-2017 | Lorusso, D; Fontanella, C; Maltese, G; Lepori, S; Tripodi, E; Bogani, G; Raspagliesi, F. | |
| Biomarker analysis of the MITO2 phase III trial of first-line treatment in ovarian cancer: predictive value of DNA-PK and phosphorylated ACC | 1-gen-2016 | Perrone, F; Baldassarre, G; Indraccolo, S; Signoriello, S; Chiappetta, G; Esposito, F; Ferrandina, G; Franco, R; Mezzanzanica, D; Sonego, M; Zulato, E; Zannoni, Gf; Canzonieri, V; Scambia, G; Sorio, R; Savarese, A; Breda, E; Scollo, P; Ferro, A; Tamberi, S; Febbraro, A; Natale, D; Di Maio, M; Califano, D; Scognamiglio, G; Lorusso, D; Canevari, S; Losito, S; Gallo, C; Pignata, S | |
| A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy | 1-gen-2011 | Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.; Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I. | |
| Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures | 1-gen-2015 | Ditto, A; Martinelli, F; Bogani, G; Lorusso, D; Carcangiu, M; Chiappa, V; Reato, C; Donfrancesco, C; De Carrillo, Kja; Raspagliesi, F | |
| Advanced vulvar carcinoma: Is it worth operating? A perioperative management protocol for radical and reconstructive surgery | 1-gen-2006 | Fanfani, Francesco; Garganese, Giorgia; Fagotti, Anna; Lorusso, D; Gagliardi Maria, Lucia; Rossi, Marco; Salgarello, Marzia; Scambia, Giovanni | |
| Feasibility Study of a Network Meta-Analysis and Unanchored Population-Adjusted Indirect Treatment Comparison of Niraparib, Olaparib, and Bevacizumab as Maintenance Therapies in Patients with Newly Diagnosed Advanced Ovarian Cancer | 1-gen-2022 | Lorusso, D; Guy, H; Samyshkin, Y; Hawkes, C; Estenson, K; Coleman, Rl; Lorusso, D; Guy, H; Samyshkin, Y; Hawkes, C; Estenson, K; Coleman, Rl | |
| Ovarian Cancer in the Era of Immune Checkpoint Inhibitors: State of the Art and Future Perspectives | 1-gen-2021 | Maiorano, Ba; Maiorano, Mfp; Lorusso, D; Maiello, E | |
| Treatment of Recurrent Endometrial Carcinoma: Progress Toward a More Personalized Approach | 1-gen-2015 | Bogani, G; Chiappa, V; Lorusso, D; Raspagliesi, F | |
| Phase II Study of NGR-hTNF Plus Doxorubicin in Relapsed Ovarian Cancer (OC) | 1-gen-2011 | Lorusso, D; Scambia, G.; Amadio, G.; Trivellizzi, N.; Pietragalla, A.; De Vincenzo, R.; Salutari, V.; Di Stefano, M.; Lambiase, A.; Bordignon, C. | |
| Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer | 1-gen-2016 | Mirza, Mr; Monk, Bj; Herrstedt, J; Oza, Am; Mahner, S; Redondo, A; Fabbro, M; Ledermann, Ja; Lorusso, D; Et, Al. | |
| Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study | 1-gen-2020 | Brewer, M; Angioli, R; Scambia, G; Lorusso, D; Terranova, C; Benedetti Panici, P; Raspagliesi, F; Scollo, P; Plotti, F; Ferrandina, G; Salutari, V; Ricci, C; Braly, P; Holloway, R; Method, M; Madiyalakan, M; Bayever, E; Nicodemus, C; Brewer, M; Angioli, R; Scambia, G; Lorusso, D; Terranova, C; Benedetti Panici, P; Raspagliesi, F; Scollo, P; Plotti, F; Ferrandina, G; Salutari, V; Ricci, C; Braly, P; Holloway, R; Method, M; Madiyalakan, M; Bayever, E; Nicodemus, C | |
| Incorporating 3D laparoscopy for the management of locally advanced cervical cancer: a comparison with open surgery | 1-gen-2016 | Raspagliesi, F; Bogani, G; Martinelli, F; Signorelli, M; Chiappa, V; Scaffa, C; Sabatucci, I; Adorni, M; Lorusso, D; Ditto, A | |
| Gynecologic Cancer InterGroup (GCIG) Consensus Review for Squamous Cell Carcinoma of the Ovary | 1-gen-2014 | Glasspool, Rm; Martin, Ag; Millan, D; Lorusso, D; Avall-Lundqvist, E; Hurteau, Ja; Davis, A; Hilpert, F; Kim, Jw; Alexandre, J; Ledermann, Ja | |
| Quality of life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer | 1-gen-2018 | Piccirillo, Mc; Scambia, G; Bologna, A; Signoriello, S; Vergote, I; Baumann, K; Lorusso, D; Murgia, V; Sorio, R; Ferrandina, G; Sacco, C; Cormio, G; Breda, E; Cinieri S, ; Natale, D; Mangili, G; Pisano, C; Cecere, Sc; Di Napoli, M; Salutari, V; Raspagliesi F, ; Arenare, L; Bergamini, A; Bryce, J; Daniele, G; Gallo, C; Pignata, S; Perrone, F. | |
| Phase II study of liposomal doxorubicin and gemcitabine in the salvage treatment of ovarian cancer | 1-gen-2003 | D'Agostino, G; Ferrandina, G; Ludovisi, M; Testa, A; Lorusso, D; Gbaguidi, N; Breda, E; Mancuso, S; Scambia, G | |
| Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study | 1-gen-2011 | Marchetti, Claudia; Pisano, Carmela; Mangili, Giorgia; Lorusso, D; Panici Pierluigi, Benedetti; Silvestro, Giustino; Candiani, Massimo; Greggi, Stefano; Perniola, Giorgia; Di Maio, Massimo; Pignata, Sandro | |
| [Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.] | 1-gen-2021 | Danesi, R.; Cremolini, C.; Ciccarone, F.; Lorusso, D. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26879
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269083
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS227
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE182
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19160
- ita408
- spa13
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24626
- reserved1362
- open891